SM

Sunitha Madhugiri Narase Gowda

Active Director Director DIN 11468874
DIN 11468874 First appointment Jan 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunitha Madhugiri Narase Gowda

Data last updated:

Sunitha Madhugiri Narase Gowda is a Director at Penumbra Healthcare Private Limited (since 2026). The company operates in Healthcare.

DIN 11468874
Primary Designation Director
Industry Healthcare
First Appointment 06 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Penumbra Healthcare Private Limited U86100KA2026PTC213775
Director06 Jan 20262026Active

Board colleagues of Sunitha Madhugiri Narase Gowda

Directorship timeline

Open interactive timeline →
Penumbra Healthcare Private Limited
Premium access

Shareholding and investment profile for Sunitha Madhugiri Narase Gowda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunitha Madhugiri Narase Gowda

Sunitha Madhugiri Narase Gowda currently holds 1 directorship: Penumbra Healthcare Private Limited (Director, since 06 Jan 2026).

Sunitha Madhugiri Narase Gowda was first appointed on 06 Jan 2026 as Director at Penumbra Healthcare Private Limited.

The current boards of Sunitha Madhugiri Narase Gowda's companies include Amogh Radhakrishna (Penumbra Healthcare Private Limited), Sudha Ranganna (Penumbra Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available